Pharmacokinetic Interaction Between SSP-004184 (SPD602) and Midazolam in Healthy Adult Subjects
NCT01989169 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2021-06-24
Summary
A Study to Evaluate the Pharmacokinetic Interaction Between SSP-004184 and Midazolam in Healthy Adult Subjects
Conditions
- Healthy
Interventions
- DRUG
-
Midazolam
- DRUG
-
SSP-004184SS
Sponsors & Collaborators
-
Shire
lead INDUSTRY
Principal Investigators
-
Study Director · Takeda
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-11-26
- Primary Completion
- 2014-01-06
- Completion
- 2014-01-06
Countries
- United States
Study Locations
More Related Trials
-
A Study to Assess the Effect of Multiple Doses of AZD5718 on Pharmacokinetics of Oral Midazolam in Healthy Subjects
NCT04492709 ·Status: COMPLETED ·Phase: PHASE1
-
A Drug to Drug Interaction Study of Sotagliflozin With Midazolam and Metoprolol
NCT02940379 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of S-740792 in Healthy Adult Study Participants
NCT06724978 ·Status: COMPLETED ·Phase: PHASE1
-
AZD1981 Midazolam CYP4503A Induction Study
NCT00859352 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
NCT05030857 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-Drug Interaction Study With AGMB-129 and Midazolam in Healthy Participants
NCT05937386 ·Status: COMPLETED ·Phase: PHASE1
-
Drug Interaction Study to Asses Multiple Doses of ZD4054 (Zibotentan)
NCT00709553 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic Interaction Trial of Clofutriben With Midazolam and Prednisolone
NCT07226635 ·Status: COMPLETED ·Phase: PHASE1
-
A Drug-Drug Interaction Study To Investigate The Ginkgolides Meglumine Injection To Alter The Pharmacokinetics Of Midazolam
NCT02233972 ·Status: COMPLETED ·Phase: PHASE4
-
A Drug-Drug Interaction Study Between GDC-0853 and Midazolam, Itraconazole, Rosuvastatin, and Simvastatin
NCT03174041 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess Drug-Drug Interaction Between ABBV-903 and Midazolam in Adult Healthy Volunteers
NCT05895266 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I, Open Interaction Study Between GLPG1837 and Midazolam in Healthy Male Subjects
NCT02562950 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-drug Interaction Study of Midazolam and AT-527 (R07496998)
NCT04865445 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-drug Interaction Study Between EDP-305, Midazolam, Caffeine and Rosuvastatin in Healthy Volunteers.
NCT03187496 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study in Healthy Volunteers to Assess the Effect of Cytochrome3A4 (CYP3A4) Inhibitors (Diltiazem and Itraconazole) on the Pharmacokinetics (PK) of AZD3293 and the Effects of AZD3293 on the Pharmacokinetics of Midazolam, a Cytochrome 3A4 and Cytochrome 3A5 (CYP3A4/CYP3A5) Substrate
NCT02010970 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Pharmacokinetics of Midazolam After Repeated Doses of Camizestrant (AZD9833) and to Investigate the Pharmacokinetics of Camizestrant When Administered Alone and in Combination With Carbamazepine in Healthy Post-Menopausal Female Participants
NCT06547164 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Effect of Phenytoin on the Drug Levels of Afimetoran and the Effect of Afimetoran on the Drug Levels of Midazolam
NCT05901714 ·Status: COMPLETED ·Phase: PHASE1
-
A Drug Interaction Study Assess the Effects of ZSP1273 Tablets on the Pharmacokinetics of Warfarin and Midazolam
NCT05942365 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-drug Interaction Study With GLPG3667 and Midazolam in Healthy Subjects
NCT04736927 ·Status: COMPLETED ·Phase: PHASE1
-
CKD-506 Drug-Drug Interaction Study in Healthy Male Subjects
NCT05238948 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Tepotinib on PK of CYP3A Substrate Midazolam
NCT03628339 ·Status: COMPLETED ·Phase: PHASE1
-
Drug Interaction Assessment of GSK3882347 in Healthy Participants Aged 18 to 65 Years
NCT05760261 ·Status: COMPLETED ·Phase: PHASE1
-
Study in Healthy Subjects to Determine the Effect of Relacorilant on Exposure to Probe Substrates for Cytochrome P450s
NCT03457597 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1, Open-label Study Evaluating the Pharmacokinetics and Drug-drug Interaction of VX-993 in Healthy Adults
NCT06392659 ·Status: COMPLETED ·Phase: PHASE1
-
Drug-Drug Interaction Study Between EDP-235, Midazolam, Caffeine and Rosuvastatin in Healthy Subjects
NCT05594615 ·Status: COMPLETED ·Phase: PHASE1